Literature DB >> 5539188

Prestone gallstone disease--is therapy safe?

D M Small.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5539188     DOI: 10.1056/NEJM197101282840412

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  The present position concerning gallstone dissolution.

Authors:  G D Bell
Journal:  Gut       Date:  1974-11       Impact factor: 23.059

2.  Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy.

Authors:  G D Bell; B Lewis; A Petrie; R H Dowling
Journal:  Br Med J       Date:  1973-09-08

3.  Liver structure and function in cholelithiasis: effect of chenodeoxycholic acid.

Authors:  G D Bell; H Y Mok; M Thwe; G M Murphy; K Henry; R H Dowling
Journal:  Gut       Date:  1974-03       Impact factor: 23.059

4.  The influence of chenodeoxycholic acid on cholesterol and bile acid turnover in humans with cholelithiasis.

Authors:  S H Quarfordt; R Jain; M R Greenfield
Journal:  Lipids       Date:  1983-02       Impact factor: 1.880

Review 5.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

6.  Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.

Authors:  D C Ruppin; G M Murphy; R H Dowling
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

7.  Medical treatment of gallstones.

Authors:  G D Bell
Journal:  J R Coll Physicians Lond       Date:  1979-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.